Skip to main content
Top

Clinical and Translational Oncology

Issue 10/2011

Content (12 Articles)

Educational Series / Blue Series

MET and VEGF: synergistic targets in castration-resistant prostate cancer

Dana T. Aftab, Donald M. McDonald

Educational Series / Green Series

Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer

Georgios V. Koukourakis, Anastasia Sotiropoulou-Lontou

Educational Series / Red Series

Synchrotron radiation in cancer treatments and diagnostics: an overview

Silvia Gil, Manuel Fernández, Yolanda Prezado, Alberto Biete, Alberto Bravin, Manel Sabés

Educational Series / Purple Series

Multidisciplinary approach of colorectal liver metastases

Ignacio Juez, Carmen Rubio, Joan Figueras

Reviews

Asthma and risk of lung cancer

María Teresa García Sanz, Francisco Javier González Barcala, José Manuel Álvarez Dobaño, Luis Valdés Cuadrado

Research Articles

Prognostic significance of biochemical markers in African Burkitt’s lymphoma

Fareed Kow Nanse Arthur, Lawrence Owusu, Francis Agyemang Yeboah, Theresa Rettig, Alex Osei-Akoto

Research Articles

Does gender matter in glioblastoma?

Eugènia Verger, Izaskun Valduvieco, Lluís Caral, Teresa Pujol, Teresa Ribalta, Núria Viñolas, Teresa Boget, Laura Oleaga, Yolanda Blanco, Francesc Graus

Research Articles

A safety and toxicity assessment of the administration of multiple intracerebral injections of irinotecan or doxorubicin drug-eluting beads

Nadine Held, Andrew L. Lewis, Hans J. Hedrich, Thomas Brinker, Silke Glage

Research Articles

Change of telomerase activity in peripheral whole blood of head and neck squamous cell carcinoma patients before and after surgery: a pilot study

Yong Seop Lee, Kyung Tae, Seung Hwan Lee, Seok Hyun Cho, Jin Hyeok Jeong, Hyun Jung Min, Yong Bae Ji

Research Articles

Molecular changes consistent with increased proliferation and invasion are common in rectal cancer

Rebecca Hughes, James Parry, John Beynon, Gareth Jenkins

Research Articles

Prevention of acute radiation enteritis: efficacy and tolerance of glutamine

Ismael Membrive Conejo, Ana Reig Castillejo, Nuria Rodríguez de Dios, Palmira Foro Arnalot, Javier Sanz Latiesas, Joan Lozano Galán, Martí Lacruz Bassols, Jaime Quera Jordana, Enric Fernández-Velilla Cepria, Manuel Algara López

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine